use-cases · 1 min read
How Bhogar AI Solves R&D and Commercial Problems in Pharma
Literature review, regulatory drafting, MSL enablement, pharmacovigilance triage and CRM intelligence - Bhogar AI built for GxP, MLR and 21 CFR Part 11.
BABhogar AI TeamProduct & Engineering
Pharma cannot use AI that does not respect GxP, MLR review and 21 CFR Part 11. Bhogar AI ships those controls as first-class concepts so scientists, MSLs and regulatory teams can adopt AI without breaking compliance.
Why it matters
Five problems show up across every top-20 pharma: literature reviews are slow, regulatory submissions are document-marathons, MSLs spend hours preparing pre-call plans, PV teams drown in case triage, and commercial teams can not get a coherent customer view. All are RAG and workflow problems with strong audit needs.
How Bhogar AI approaches it
Bhogar AI tackles each with grounded agents tied to validated KBs, MLR-aware workflows, eval pipelines for clinical accuracy, and per-environment validation packages for GxP systems.
- Literature: agent searches, summarises and cites - never inventing a reference
- Regulatory drafting: section-aware writing agents with template enforcement
- MSL: pre-call brief from CRM + literature with disclosure controls
- PV: triage workflow ranks ICSRs, drafts narratives for medical review
- Commercial: account-360 agent unifies CRM, claims and field data
- Validation pack ships with each release; audit trail meets 21 CFR Part 11
What you get
Pharma teams move faster on the work that matters while keeping the validation, MLR and PV controls auditors expect.